- Home
- ORMP vs ATRA Comparison
ORMP vs ATRA Comparison
Compare ORMP & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- ATRA
- Stock Information
- Founded
- ORMP 2002
- ATRA 2012
- Country
- ORMP United States
- ATRA United States
- Employees
- ORMP N/A
- ATRA N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORMP Health Care
- ATRA Health Care
- Exchange
- ORMP Nasdaq
- ATRA Nasdaq
- Market Cap
- ORMP 104.6M
- ATRA 97.0M
- IPO Year
- ORMP N/A
- ATRA 2014
- Fundamental
- Price
- ORMP $2.23
- ATRA $14.81
- Analyst Decision
- ORMP
- ATRA Strong Buy
- Analyst Count
- ORMP 0
- ATRA 3
- Target Price
- ORMP N/A
- ATRA $21.00
- AVG Volume (30 Days)
- ORMP 135.7K
- ATRA 63.6K
- Earning Date
- ORMP 11-06-2025
- ATRA 11-11-2025
- Dividend Yield
- ORMP N/A
- ATRA N/A
- EPS Growth
- ORMP N/A
- ATRA N/A
- EPS
- ORMP N/A
- ATRA 0.56
- Revenue
- ORMP $2,000,000.00
- ATRA $188,667,000.00
- Revenue This Year
- ORMP N/A
- ATRA N/A
- Revenue Next Year
- ORMP N/A
- ATRA N/A
- P/E Ratio
- ORMP N/A
- ATRA $26.29
- Revenue Growth
- ORMP N/A
- ATRA 202.41
- 52 Week Low
- ORMP $1.82
- ATRA $5.01
- 52 Week High
- ORMP $3.09
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- ORMP 40.47
- ATRA 56.60
- Support Level
- ORMP $2.19
- ATRA $14.01
- Resistance Level
- ORMP $2.47
- ATRA $16.28
- Average True Range (ATR)
- ORMP 0.13
- ATRA 1.08
- MACD
- ORMP -0.04
- ATRA -0.05
- Stochastic Oscillator
- ORMP 10.20
- ATRA 46.11
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).